Can the fall in serum FSH during coasting in IVF/ICSI predict clinical outcomes?

Reproductive BioMedicine Online

Volumn 24, Issue 5, 2012, Pages 503-510

  Datta, Adrija Kumar ^a,b   Zosmer, Ariel ^a   Tozer, Amanda ^a   Sabatini, Luca ^a   Davis, Colin ^a   Al Shawaf, Talha ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b Midland Fertility Services   (United Kingdom)

Author keywords

coasting; FSH fall; FSH monitoring; IVF ICSI; oestradiol fall; OHSS

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIRTH RATE; BODY MASS; CONTROLLED STUDY; DOWN REGULATION; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; NIDATION; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; PREDICTION; PREGNANCY RATE; RETROSPECTIVE STUDY;

ADULT; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; COHORT STUDIES; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; INFERTILITY, FEMALE; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME;

EID: 84861098671     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2012.02.004     Document Type: Article

References (29)

1. H. Abdalla, and J.D. Nicopoullos The effect of duration of coasting and estradiol drop on the outcome of assisted reproduction: 13 years of experience in 1068 coasted cycles to prevent ovarian hyperstimulation Fertil. Steril. 94 2010 1757 1763
2. Al-Inany, H.G., Youssef, M.A., Aboulghar, M., Broekmans, F., Sterrenburg, M., Smit, J., Abou-Setta, A.M., 2011. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev, CD001750.
3. T. Al-Shawaf, A. Zosmer, S. Hussain, A. Tozer, N. Panay, C. Wilson, A.M. Lower, and J.G. Grudzinskas Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients Hum. Reprod. 16 2001 24 30
4. T. Al-Shawaf, A. Zosmer, A. Tozer, C. Gillott, A.M. Lower, and J.G. Grudzinskas Value of measuring serum FSH in addition to serum estradiol in a coasting programme to prevent severe OHSS Hum. Reprod. 17 2002 1217 1221
5. M. Bahceci, U. Ulug, S. Tosun, H.F. Erden, and N. Bayazit Impact of coasting in patients undergoing controlled ovarian stimulation with the gonadotropin-releasing hormone antagonist cetrorelix Fertil. Steril. 85 2006 1523 1525
6. Z. Ben-Rafael, T. Levy, and J. Schoemaker Pharmacokinetics of follicle-stimulating hormone: clinical significance Fertil. Steril. 63 1995 689 700
7. C.A. Benadiva, O. Davis, I. Kligman, M. Moomjy, H.C. Liu, and Z. Rosenwaks Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome Fertil. Steril. 67 1997 724 727
8. J.B. Brown Pituitary control of ovarian function-concepts derived from gonadotrophin therapy Aus. N. Z. J. Obst. Gynaecol. 18 1978 46 54
9. P.E. Chenette, M.V. Sauer, and R.J. Paulson Very high serum estradiol levels are not detrimental to clinical outcome of in vitro fertilization Fertil. Steril. 54 1990 858 863
10. D'Angelo, A., Amso, N., 2002. 'Coasting' (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev, CD002811.
11. A. Delvigne, K. Kostyla, D. Murillo, J. Van Hoeck, and S. Rozenberg Oocyte quality and IVF outcome after coasting to prevent ovarian hyperstimulation syndrome Int. J. Fertility Women's Med. 48 2003 25 31
12. P.E. Egbase, M. al Sharhan, P. Berlingieri, and J.G. Grudzinskas Serum oestradiol and progesterone concentrations during prolonged coasting in 15 women at risk of ovarian hyperstimulation syndrome following ovarian stimulation for assisted reproduction treatment Hum. Reprod. 15 2000 2082 2086
13. M. Erman Akar, and K. Oktay Falling FSH levels predict poor IVF pregnancy rates in patients whom the gonadotropins are withheld Arch. Gynecol. Obstet. 280 2009 761 765
14. J. Farhi, A. Ben-Haroush, Y. Lande, O. Sapir, H. Pinkas, and B. Fisch In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols Fertil. Steril. 91 2009 377 382
15. M.R. Fluker, W.M. Hooper, and A.A. Yuzpe Withholding gonadotropins ('coasting') to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles Fertil. Steril. 71 1999 294 301
16. P. Kovacs, S. Matyas, and S.G. Kaali Effect of coasting on cycle outcome during in vitro fertilization/intracytoplasmic sperm injection cycles in hyper-responders Fertil. Steril. 85 2006 913 917
17. D. Kyrou, B. Popovic-Todorovic, H.M. Fatemi, C. Bourgain, P. Haentjens, L. Van Landuyt, and P. Devroey Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist? Hum. Reprod. 24 2009 2902 2909
18. R. Mansour, M. Aboulghar, G. Serour, Y. Amin, and A.M. Abou-Setta Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome Hum. Reprod. 20 2005 3167 3172
19. L. Mettler, and E.N. Tavmergen Significance of oestradiol values in IVF-ET under a combined GnRH analogue-desensitization and simultaneous gonadotrophin stimulation for the outcome of pregnancies Hum. Reprod. 4 1989 59 64
20. L. Moreno, I. Diaz, A. Pacheco, A. Zuniga, A. Requena, and J.A. Garcia-Velasco Extended coasting duration exerts a negative impact on IVF cycle outcome due to premature luteinization Reprod. Biomed. online 9 2004 500 504
21. L.G. Nardo, P. Cheema, T.A. Gelbaya, G. Horne, C.T. Fitzgerald, E.H. Pease, D.R. Brison, and B.A. Lieberman The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization Hum. Fertil. (Camb) 9 2006 175 180
22. M. Owj, E. Tehrani Nejad, E. Amirchaghmaghi, Z. Ezabadi, and A.R. Baghestani The effect of withholding gonadotropin (a coasting period) on the outcome of in vitro fertilization cycles Eur. J. Obstet. Gynecol. Reprod. Biol. 133 2007 81 85
23. O. Ozdegirmenci, S. Dilbaz, O. Cinar, S. Aydin, G. Beydilli, L. Cakir, E.S. Guven, M. Akyol, and A. Haberal Can serum oestradiol be a predictor of quality of oocytes and embryos, maturation of oocytes and pregnancy rate in ICSI cycles? Gynecol. Endocrinol.: The Off. J. Int. Soc. Gynecol. Endocrinol. 27 2011 279 285
24. G. Sher, C. Zouves, M. Feinman, and G. Maassarani 'Prolonged coasting': an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization Hum. Reprod. 10 1995 3107 3109
25. C. Simon, F. Cano, D. Valbuena, J. Remohi, and A. Pellicer Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients Hum. Reprod. 10 1995 2432 2437
26. D.V. Tortoriello, P.G. McGovern, J.M. Colon, J.H. Skurnick, K. Lipetz, and N. Santoro 'Coasting' does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients Fertil. Steril. 69 1998 454 460
27. U. Ulug, I. Ben-Shlomo, and M. Bahceci Predictors of success during the coasting period in high-responder patients undergoing controlled ovarian stimulation for assisted conception Fertil. Steril. 82 2004 338 342
28. Vitthala, S., Bouaziz, J., Tozer, A., Zosmer, A., Al-Shawaf, T., 2012. Serum FSH levels in coasting programmes on the hCG day and their clinical outcomes in IVF ± ICSI cycles. Int. J. Endocrinol. 2012, Article ID 540681.
29. U. Waldenstrom, J. Kahn, L. Marsk, and S. Nilsson High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by 'prolonged coasting' of very hyperstimulated patients: a multicentre study Hum. Reprod. 14 1999 294 297